Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377964 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
A series of novel cyclobutane derivatives as potent and selective NK1 receptor antagonists is described. Several compounds in this series exhibited high in vitro binding affinity (Ki ⩽ 1 nM), and potent inhibition of central NK1 receptor following oral administration. Syntheses of these compounds are also described herein.
Graphical abstractThe discovery of a novel series of cyclobutane derivatives 3 as potent and orally active NK1 selective antagonists is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Michelle Laci Wrobleski, Gregory A. Reichard, Sunil Paliwal, Sapna Shah, Hon-Chung Tsui, Ruth A. Duffy, Jean E. Lachowicz, Cynthia A. Morgan, Geoffrey B. Varty, Neng-Yang Shih,